3Trodella L,Granone P,Valente S,et al.Adjuvant radiotherapy in non-small cell lung cancer with pathological stage Ⅰ:definitive results of a phase Ⅲ randomized trial[J].J Radiother Oncol,2002,62:11-19.
4Therasse P,Arbuek SG, Eisenhauer EA, t al. New guidelines to evaluate the response to treatment in solid tumors[J].J Nail Cancer lnst,2000, 92: 205-216.
5Thatcher N, Chang A, Parikh P, et al. 6efitinib plus best supportive carein previously treated patients with refractory advanced non-small- cell lung cancer: results from a randomized, placebo-cont Toned multicentre study(Iressa Survival Evaluation in Lung Cancer)[J]. Lancet, 2005, 366: 1527-1537.
6Satouchi M, Negoro S, Funada Y, et al. Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLO t rea ted wi thgeni f i t i b [J]. Br JCancer, 2007,96 1191-1196.
8Lind Js, Meijerink MR, Dingemans AM, et al. Dynamic contrast enhanced CT in patients treated with sorafenib and edotinib fornon-small cell lung cancer: a new method of monitoring treatment [J]. gur Radiol, 2010, 20: 2890-2898.
